Workflow
SLAC(300382)
icon
Search documents
斯莱克(300382) - 关于公司第五期员工持股计划第三个解锁期公司业绩考核指标未达成的公告
2025-05-16 11:36
证券代码:300382 证券简称:斯莱克 公告编号:2025-063 苏州斯莱克精密设备股份有限公司 关于公司第五期员工持股计划第三个解锁期 公司业绩考核指标未达成的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 苏州斯莱克精密设备股份有限公司(以下简称"公司")于2025年5月16日 召开第六届董事会第七次会议和第六届监事会第六次会议,审议通过了《关于 公司第五期员工持股计划第三个解锁期公司业绩考核指标未达成的议案》,有 关事项具体如下: 一、本员工持股计划概述 4、公司于 2023 年 3 月 14 日披露了《关于公司第五期员工持股计划第一个 锁定期限届满的提示性公告》,第五期员工持股计划(以下简称"本员工持股计 划")第一个解锁期于 2023 年 3 月 9 日届满,解锁比例为本员工持股计划持股 总数的 20% , 具体内容详见公司于 2023 年 3 月 14 日在巨潮资讯网 (http://www.cninfo.com.cn)披露的相关公告。 5、公司于 2023 年 5 月 18 日召开第五届董事会第二十九次会议、第五届监 事会第二十五次会议 ...
斯莱克(300382) - 300382斯莱克业绩说明会20250513
2025-05-14 09:28
Group 1: Business Development and Market Expansion - The company is expanding its battery structure component business in the U.S. through its subsidiary OKL, with plans for mass production after equipment installation and debugging [2] - The overall sales volume of battery shells in 2024 is projected to be 175 million units, primarily square battery shells [3] - The company has signed a strategic cooperation agreement for the production of large cylindrical battery shells with Yantai Lihua Power Technology Co., Ltd. [4] Group 2: Financial Performance and Profitability - The company aims to achieve a net profit margin of around 15% in the future, leveraging its advanced technology and high material utilization [7] - The company’s battery shell business is still in its early stages, with significant profit increases expected to take time [4] - The market for harmonic reducers is projected to grow from approximately 1.57 billion yuan in 2020 to 4.7 billion yuan by 2025, with a compound annual growth rate of about 25% [6] Group 3: Business Strategy and Operations - The company is diversifying its operations across various sectors, including new energy battery shells and can/cover equipment, while also exploring the application of its technology in robotic harmonic reducer components [5] - The company emphasizes the importance of resource allocation, capability transfer, and technology sharing among its diverse business units to enhance overall competitiveness [8] - The company has implemented multiple employee incentive plans, including stock options and employee stock ownership plans, to motivate core talent [7]
超8亿!力华电源下发46大圆柱结构件订单
鑫椤锂电· 2025-05-14 06:34
关注公众号,点击公众号主页右上角" ··· ",设置星标 "⭐" ,关注 鑫椤锂电 资讯~ 本文来源:企业公告 5月12日消息, 苏州斯莱克精密设备股份有限公司披露其与烟台力华电源科技有限公司就力华电源46系列大圆柱 电池合作事宜达成意向。 会议详情 I C C S I N O 根据《战略合作协议》,双方将持续推进在46系列大圆柱电池零部件的开发合作,斯莱克将充分利用在大圆柱电 池精密安全结构件领域的优势,助力力华电源开发具有高倍率性能、高能量密度、长循环寿命、极致安全的电池产 品。当合作项目出现对合作产品的需求时,双方应在同等条件下优先推介和采购合作产品。 双方合作的产品包括: 46系列大圆柱电池结构件、电池生产线自动化改造服务、电池PACK所需的产品。5年内, 力华电源采购46系列大圆柱电池结构件的数量为2亿套。 公告显示,斯莱克凭借在易拉罐生产设备领域积累的研发成果及生产经验,向新能源电池壳智能生产线、工业互联 网等相关领域延伸,基于易拉罐生产设备特有的DWI超薄金属成型技术,将现有制罐技术应用于新能源汽车电池壳 的制造,研发出46系列大圆柱电池壳等高速自动化生产方式,其利用易拉罐高速产线的规模化、智能 ...
超8亿!力华电源下发46大圆柱结构件订单
起点锂电· 2025-05-13 10:01
Core Viewpoint - The collaboration between Sileck and Yantai Lihua Power Technology marks a significant step towards the maturity of the cylindrical battery industry, with increasing positive signals in the supply chain and a trend towards normalized upstream and downstream order cooperation [1][4]. Group 1: Strategic Cooperation - Sileck signed a strategic cooperation agreement with Yantai Lihua Power to collaborate on the development and market promotion of the 46 series cylindrical batteries, including components and automation services [1]. - The agreement includes a plan for Yantai Lihua to purchase 200 million sets of cylindrical battery components over the next five years, translating to an estimated order value of approximately 800-1,000 million yuan [1]. Group 2: Company Background - Yantai Lihua Power was established on March 9, 2023, with a registered capital of 200 million yuan, focusing on high energy density, long cycle life, and high-rate performance cylindrical batteries [2]. - The company is backed by five major shareholders, including state-owned enterprises, with a significant investment of 10 billion yuan in a 25GWh cylindrical battery project in Yantai [2]. Group 3: Production Capacity and Financial Projections - The first phase of the project is expected to be operational by June 2025, with a production capacity of 4GWh for cylindrical lithium iron phosphate cells, generating an annual output value of 2.2 billion yuan and tax revenue of 300 million yuan [3]. Group 4: Market Trends and Future Outlook - Sileck's collaboration with Yantai Lihua Power signifies recognition of its 46 series battery shell, which benefits from advanced production techniques and high material utilization [4]. - The demand for cylindrical battery shells is growing significantly, with Sileck already engaging in deep cooperation with major companies like CATL and Tesla, indicating a robust market potential [5]. - The global market for lithium battery structural components is projected to exceed 65 billion yuan in the next two years, with Sileck poised to leverage its DWI metal precision processing technology for new growth opportunities [5].
公告精选丨中国中车:近期签订合计547.4亿元重大合同;沃尔核材:筹划发行H股股票并申请在香港联交所主板上市
今日焦点中国中车:近期签订合计547.4亿元重大合同 中国中车公告称,公司及下属企业于近期(主要为2024年12月至2025年5月)签订了若干项重大合同, 合计金额约547.4亿元人民币。主要合同包括城市轨道车辆、设备销售及维保合同,动车组销售合同, 动车组高级修合同,风电设备销售合同和储能设备销售合同,机车销售合同以及货车修理合同。上述合 同总金额约占公司中国会计准则下2024年营业收入的22.2%。 阳光诺和:拟购买朗研生命100%股权,股票明日复牌 南方财经5月12日电,阳光诺和(688621.SH)公告称,公司拟通过发行股份及可转换公司债券购买资产并 募集配套资金,购买利虔、朗颐投资等38名朗研生命股东持有的朗研生命100%股权。并向不超过35名 特定投资者发行股份募集配套资金。朗研生命专注于高端化学药及原料药的研发、生产和销售,并对外 提供药品生产服务,在高端化学药、原料药等领域深耕多年,已经形成了较为成熟的医药生产体系。公 司股票将于5月13日开市起复牌。 沃尔核材:筹划发行H股股票并申请在香港联交所主板上市 沃尔核材公告称,公司拟发行H股股票并申请在香港联交所主板挂牌上市,以推进国际化战略,提升 ...
突发!320亿人形机器人概念股股东拟减持不超1.5%股份|盘后公告集锦
Xin Lang Cai Jing· 2025-05-12 12:27
Company Announcements - Zhaowei Electromechanical plans to reduce its shareholding by no more than 1.5%, equating to approximately 3.6 million shares [1] - China CNR Corporation has signed several major contracts totaling approximately 54.74 billion yuan, representing about 22.2% of its expected revenue for 2024 [2] - Yunnan Copper is planning to acquire a 40% stake in Liangshan Mining, leading to a temporary suspension of its stock [2] - Sunshine Nuohua intends to acquire 100% of Langyan Life, with its stock set to resume trading [3] - Wolong Materials is planning to issue H-shares and apply for a listing on the Hong Kong Stock Exchange [3] - Hanyu Pharmaceutical has signed a joint development agreement for a novel peptide drug targeting metabolic diseases [3] - Lijun Co. confirms that its operations are normal and there are no undisclosed significant matters [3] Investments & Acquisitions - China Medical plans to acquire 100% of Jinsui Technology for 302 million yuan [4] - Shuangyi Technology intends to acquire 100% of Marky Industries for 18 million AUD, along with specific assets [5] Strategic Partnerships - Sileck has signed a strategic cooperation agreement with Lihua Power for the development of large cylindrical batteries [6] - Hongchang Technology plans to invest 15 million yuan in a humanoid robot industry chain company [7] - Macroview Technology is establishing a wholly-owned subsidiary focused on artificial intelligence [8] - Yihua Jiaye has signed a strategic cooperation framework agreement with Hanyu Pharmaceutical and Hanyu Health to develop a sleep health ecosystem [9] - Wanda Film is investing in Lezi Tiancheng and will engage in strategic cooperation in IP toy product development [10] Shareholding Changes - Tiandi Online's controlling shareholder is transferring 6.97% of its shares to introduce a strategic investor [12] - Longjiang Transportation plans to reduce its shareholding by no more than 3% [13] - Boyun New Materials intends to reduce its shareholding by no more than 3% [14] - Tongrun Equipment's major shareholder plans to reduce its stake by no more than 2% [15] Financing & Capital Increase - Tangyuan Electric plans to raise no more than 864 million yuan through a private placement [16] - Shangsheng Electronics intends to issue convertible bonds to raise up to 330 million yuan [17] Other Developments - Xianju Pharmaceutical has obtained a domestic production registration certificate for Dydrogesterone tablets [18] - Rongchang Bio has received a clinical trial application acceptance notice for its antibody-drug conjugate RC278 [19] - Jiangsu Leili's subsidiary Dingzhi Technology is implementing a stock incentive plan [20]
斯莱克(300382):点评报告:一季度收入同比增长55%,电池壳、人形机器人减速器放量在即
ZHESHANG SECURITIES· 2025-05-12 12:25
Investment Rating - The investment rating for the company is "Buy" [5] Core Insights - In Q1 2025, the company achieved revenue of 530 million yuan, a year-on-year increase of 55%, but the net profit attributable to shareholders decreased by 43% to 11.59 million yuan [1] - For the year 2024, the company reported revenue of 1.51 billion yuan, a year-on-year decrease of 8%, and a net loss of 140 million yuan, primarily due to cyclical fluctuations in traditional equipment business and challenges in the new energy battery shell business [1][2] - The battery shell business revenue in 2024 grew by 51% year-on-year, continuing a trend of over 50% growth for three consecutive years, with plans to expand production capacity in the U.S. [2] - The company is on the verge of mass production of humanoid robots, with significant demand expected in the manufacturing and domestic service sectors, potentially reaching 2.1 million units by 2030 [3] - The company forecasts revenues of 1.886 billion yuan in 2025, with a projected net profit of 127 million yuan, marking a turnaround from losses [5] Summary by Sections Financial Performance - Q1 2025 revenue was 530 million yuan, up 55% year-on-year; net profit was 11.59 million yuan, down 43% [1] - 2024 revenue was 1.51 billion yuan, down 8%; net loss was 140 million yuan [1] - Forecasted revenues for 2025, 2026, and 2027 are 1.886 billion, 2.343 billion, and 2.880 billion yuan respectively, with net profits expected to be 127 million, 162 million, and 209 million yuan [5] Business Segments - The battery shell business is expected to contribute significantly to revenue, with a 51% year-on-year growth in 2024 [2] - The company is developing a new production line for harmonic reducers, which are critical components for humanoid robots, indicating a new growth avenue [3] Market Outlook - The company anticipates a compound annual growth rate (CAGR) of 28% from 2025 to 2027, with corresponding price-to-earnings (P/E) ratios of 76, 59, and 46 [3][5]
斯莱克:与力华电源签署46系列大圆柱电池战略合作协议
news flash· 2025-05-12 11:09
斯莱克:与力华电源签署46系列大圆柱电池战略合作协议 智通财经5月12日电,斯莱克(300382.SZ)公告称,公司近日与烟台力华电源科技签署《战略合作协 议》,就力华电源46系列大圆柱电池合作事宜达成一致意向。该协议为初步框架协议,具体实施进展存 在不确定性。力华电源主要从事高倍率性能、高能量密度、长循环寿命、极致安全的储能系列大圆柱电 池的研发制造。 ...
斯莱克(300382) - 国投证券股份有限公司关于苏州斯莱克精密设备股份有限公司2022年度创业板向特定对象发行股票之保荐总结报告书
2025-05-12 11:02
国投证券股份有限公司 关于苏州斯莱克精密设备股份有限公司 2022 年度创业板向特定对象发行股票之保荐总结报告书 国投证券股份有限公司(以下简称"国投证券"、"保荐机构")作为苏州 斯莱克精密设备股份有限公司(以下简称"斯莱克"或"公司")创业板向特定 对象发行股票的保荐机构,持续督导期至 2024 年 12 月 31 日。截至目前,持续 督导期限已满,保荐机构现根据《证券发行上市保荐业务管理办法》等相关规定, 出具本保荐总结报告书。 一、保荐机构及保荐代表人承诺 1、本保荐总结报告书和证明文件及其相关资料的内容不存在虚假记载、误 导性陈述或重大遗漏,保荐机构及保荐代表人对其真实性、准确性、完整性承担 法律责任。 2、保荐机构及保荐代表人自愿接受中国证券监督管理委员会(以下简称"中 国证监会")对本保荐总结报告书相关事项进行的任何质询和调查。 3、保荐机构及保荐代表人自愿接受中国证监会按照《证券发行上市保荐业 务管理办法》等有关规定采取的监管措施。 二、保荐机构基本情况 | 保荐机构: | 国投证券股份有限公司 | | --- | --- | | 注册地址: | 深圳市福田区福田街道福华一路 119 号安信金 ...
斯莱克(300382) - 关于公司签署战略合作协议的自愿性披露公告
2025-05-12 11:02
证券代码:300382 证券简称:斯莱克 公告编号:2025-059 苏州斯莱克精密设备股份有限公司 关于公司签署《战略合作协议》的自愿性披露公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 根据《深圳证券交易所创业板股票上市规则》等相关法律法规及《公司章程》 的要求,上述交易无需提交公司董事会、股东会审议。上述交易事项不涉及关联 交易,也不构成《上市公司重大资产重组管理办法》规定的重大资产重组。现将 有关事项公告如下: 二、合作对方基本情况 1、单位名称:烟台力华电源科技有限公司 特别提示: 1、本次签订的合作协议为初步框架协议,确立了双方合作关系,双方后续 的合作以具体签订的合同为准,具体实施进展尚存在不确定性。 2、本协议预计对公司 2025 年经营业绩不构成重大影响,对公司未来经营业 绩的影响将视具体业务的推进和实施情况而定。敬请广大投资者谨慎决策,注意 投资风险。 3、公司不存在最近三年披露的框架协议进展未达预期的情况。 一、协议签署情况 苏州斯莱克精密设备股份有限公司(以下简称"公司")近日与烟台力华电 源科技有限公司(以下简称"力华电源")经 ...